EHE Health and GRAIL Partner to Offer Galleri Multi-Cancer Early Detection Test
In a groundbreaking move towards enhancing cancer detection capabilities, EHE Health, a leading provider in preventive healthcare, has announced its partnership with GRAIL, a pioneer in innovative cancer diagnostic technologies. This collaboration will enable select EHE members to access the Galleri® multi-cancer early detection (MCED) test. The Galleri test is significant as it focuses on detecting various cancers that currently lack traditional screening methods. As part of EHE's commitment to proactive healthcare, the Galleri test will serve as a valuable addition for those over 50 years old, specifically aimed at individuals who are not undergoing active cancer treatment.
One of the most alarming aspects of cancer is that nearly 70% of cancer-related fatalities are attributed to types that don’t have standard screening protocols. GRAIL has developed the Galleri test to fill this critical gap. This test is designed to identify signals relating to more than 50 different cancers, including formidable varieties like pancreatic, ovarian, and liver cancers, which often present without early symptoms. Studies confirm that the Galleri test boasts a remarkable accuracy rate exceeding 90%, making it a reliable tool for early cancer detection.
Eligible members of EHE Health can avail themselves of the Galleri test at a discounted rate of $799, after an exclusive reduction of $150 following their initial EHE exam. To initiate the testing process, members will have a comprehensive consultation with an independent clinical provider who will assess their suitability for the test. If approved, members can opt for a blood draw either at a Quest Diagnostics location or through an at-home phlebotomist, ensuring convenience and accessibility. After necessary laboratory procedures, the results and any follow-up care management will be coordinated through the same independent clinical provider.
Dr. Neal Mills, Chief Medical Officer at EHE Health, emphasized the organization's ongoing dedication to integrating emerging healthcare technologies in their offerings. He stated, "This partnership with GRAIL illustrates our mission to promote evidence-based healthcare, allowing for timely evaluations through avant-garde screening approaches."
Echoing this sentiment, Megan Hall, PhD, Vice President of Medical Affairs at GRAIL, remarked, "By expanding the accessibility of advanced screening tools like Galleri, we aim to facilitate earlier cancer detections. This collaboration with EHE Health is a vital step towards refining preventive healthcare strategies."
Starting mid-July, EHE Health members will be able to utilize their discount on the Galleri test. Awareness about effective and accessible cancer screening options can significantly transform healthcare outcomes, making it essential for individuals, particularly those in the high-risk category, to stay informed and proactive.
For those seeking additional information on the Galleri test, including its operational mechanics and clinical validity, it is advisable to visit the official GRAIL website at www.grail.com/galleri-test/the-test/.
About EHE Health:
For more than a century, EHE Health has positioned itself as a trailblazer in preventive healthcare. With roots deeply embedded in innovation and patient care, the organization supports mid and large-sized employers in integrating comprehensive healthcare solutions for their employees. Headquartered in New York City, EHE operates over 200 health clinics nationwide, operating under a framework that prioritizes preventive care. Recognized by both Fortune Magazine and Great Place to Work® as one of the best healthcare workplaces, EHE Health remains steadfast in its mission to promote longer, healthier lives through personalized preventative strategies.
One of the most alarming aspects of cancer is that nearly 70% of cancer-related fatalities are attributed to types that don’t have standard screening protocols. GRAIL has developed the Galleri test to fill this critical gap. This test is designed to identify signals relating to more than 50 different cancers, including formidable varieties like pancreatic, ovarian, and liver cancers, which often present without early symptoms. Studies confirm that the Galleri test boasts a remarkable accuracy rate exceeding 90%, making it a reliable tool for early cancer detection.
Eligible members of EHE Health can avail themselves of the Galleri test at a discounted rate of $799, after an exclusive reduction of $150 following their initial EHE exam. To initiate the testing process, members will have a comprehensive consultation with an independent clinical provider who will assess their suitability for the test. If approved, members can opt for a blood draw either at a Quest Diagnostics location or through an at-home phlebotomist, ensuring convenience and accessibility. After necessary laboratory procedures, the results and any follow-up care management will be coordinated through the same independent clinical provider.
Dr. Neal Mills, Chief Medical Officer at EHE Health, emphasized the organization's ongoing dedication to integrating emerging healthcare technologies in their offerings. He stated, "This partnership with GRAIL illustrates our mission to promote evidence-based healthcare, allowing for timely evaluations through avant-garde screening approaches."
Echoing this sentiment, Megan Hall, PhD, Vice President of Medical Affairs at GRAIL, remarked, "By expanding the accessibility of advanced screening tools like Galleri, we aim to facilitate earlier cancer detections. This collaboration with EHE Health is a vital step towards refining preventive healthcare strategies."
Starting mid-July, EHE Health members will be able to utilize their discount on the Galleri test. Awareness about effective and accessible cancer screening options can significantly transform healthcare outcomes, making it essential for individuals, particularly those in the high-risk category, to stay informed and proactive.
For those seeking additional information on the Galleri test, including its operational mechanics and clinical validity, it is advisable to visit the official GRAIL website at www.grail.com/galleri-test/the-test/.
About EHE Health:
For more than a century, EHE Health has positioned itself as a trailblazer in preventive healthcare. With roots deeply embedded in innovation and patient care, the organization supports mid and large-sized employers in integrating comprehensive healthcare solutions for their employees. Headquartered in New York City, EHE operates over 200 health clinics nationwide, operating under a framework that prioritizes preventive care. Recognized by both Fortune Magazine and Great Place to Work® as one of the best healthcare workplaces, EHE Health remains steadfast in its mission to promote longer, healthier lives through personalized preventative strategies.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.